Reliance Plans on Covid With Cheaper Tests, New Tapeworm Drug

India has emerged as the pandemic’s epicenter with the world’s fastest-surging coronavirus outbreak. In this way, Nothing to astonish that Reliance Industries Ltd is venturing into exploring the use of a tapeworm drug, Niclosamide, as a cure for Covid-19, according to its annual report. The diagnostic kits for this drug — R-Green and R-Green Pro — have already been approved by India’s apex medical research body.

Reliance said in the report that they have designed a process to make sanitizers at one-fifth the market cost.

Reliance is also trying to look into ventilator shortages across Indian hospitals that have been faced earlier. This year they are going to use 3D technology and a “special snorkeling mask. They are also designing medical-grade oxygen generators with five to seven liter capacity per minute, the report said.

Reliance repurposed its plants in Jamnagar When India faced a huge oxygen shortage during the second wave in April which is the world’s biggest oil refinery site to produce medical-grade oxygen. Last year, they also set up a unit to make personal protective equipment kits for the front-line health care workers.

Leave a Reply

Your email address will not be published. Required fields are marked *